论文部分内容阅读
目的探讨原发性肝癌的多种介入治疗方法及应用效果。方法对照组给予单纯介入灌注化疗和栓塞,研究组经介入化疗栓塞(TACE)联合射频消融介入(RFA)治疗,记录两组原发性肝癌患者临床疗效。结果两组原发性肝癌患者均顺利完成上述相应治疗,研究组临床总有效率高达82.22%,对照组临床总有效率仅为62.22%,提示研究组疗效优于对照组,数据对比差异显著(P<0.05,有统计学意义)。结论对原发性肝癌患者给予TACE联合RFA治疗可显著提高其临床疗效,有利于提高患者生活质量及生命安全,值得推广应用。
Objective To explore a variety of interventional treatment of primary liver cancer and its application results. Methods The control group was given chemotherapy and embolization by simple percutaneous infusion. The study group was treated by interventional chemotherapy and embolization (TACE) combined with radiofrequency catheter ablation (RFA). The clinical efficacy of the two groups of patients with primary liver cancer was recorded. Results The two groups of patients with primary liver cancer were successfully completed the above treatment, the study group, the total effective rate as high as 82.22%, the control group, the total effective rate was 62.22%, suggesting that the efficacy of the study group was better than the control group, the data significant differences P <0.05, with statistical significance). Conclusions The combination of TACE and RFA can significantly improve the clinical curative effect of patients with primary liver cancer, which is beneficial to improve the quality of life and safety of patients. It is worth popularizing and applying.